Long-term Cost-effectiveness of Insulin Degludec Versus Insulin Glargine U100 in the UK: Evidence from the Basal-bolus Subgroup of the DEVOTE Trial (DEVOTE 16)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1896
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Long-term Cost-effectiveness of Insulin Degludec Versus Insulin Glargine U100 in the UK: Evidence from the Basal-bolus Subgroup of the DEVOTE Trial (DEVOTE 16) ; volume:17 ; number:5 ; day:2 ; month:7 ; year:2019 ; pages:615-627 ; date:10.2019
Applied health economics and health policy ; 17, Heft 5 (2.7.2019), 615-627, 10.2019
- Creator
-
Pollock, Richard
Valentine, William J.
Marso, Steven P.
Andersen, Andreas
Gundgaard, Jens
Hallén, Nino
Tutkunkardas, Deniz
Magnuson, Elizabeth A.
Buse, John B.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40258-019-00494-3
- URN
-
urn:nbn:de:101:1-2020013100570890142651
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pollock, Richard
- Valentine, William J.
- Marso, Steven P.
- Andersen, Andreas
- Gundgaard, Jens
- Hallén, Nino
- Tutkunkardas, Deniz
- Magnuson, Elizabeth A.
- Buse, John B.
- SpringerLink (Online service)
Other Objects (12)
DEVOTE 5: Evaluating the Short-Term Cost-Utility of Insulin Degludec Versus Insulin Glargine U100 in Basal–Bolus Regimens for Type 2 Diabetes in the UK
Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
La Dévote
"Devote Kritik"
Sainte-Dévote
Lector Devote
Lector Devote
"Devote Begrüßung"
Orationi devote
Orationi devote
DEVOTE 5: Evaluating the Short-Term Cost-Utility of Insulin Degludec Versus Insulin Glargine U100 in Basal–Bolus Regimens for Type 2 Diabetes in the UK
Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
La Dévote
"Devote Kritik"
Sainte-Dévote
Lector Devote
Lector Devote
"Devote Begrüßung"
Orationi devote
Orationi devote
DEVOTE 5: Evaluating the Short-Term Cost-Utility of Insulin Degludec Versus Insulin Glargine U100 in Basal–Bolus Regimens for Type 2 Diabetes in the UK
Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
La Dévote
"Devote Kritik"
Sainte-Dévote
Lector Devote
Lector Devote
"Devote Begrüßung"
Orationi devote